CaseStudy

Client

Client Need

Solution Approach

Results Innovator partners in India to collaborate on a new

class of proteins - Anticalins® to develop various programs in Oncology and Ophthalmology.

German Biotech company making safer, effective and differentiated Novel drugs

Aagami identified right partners, and took them to 7 interested companies for Anticalins®

With focused efforts 3 companies moved to term sheet level discussions. Aagami kept facilitating and persevering. 2 companies remained for final negotiations.

Aagami maintained its spirits and perseverance knowing Indian ways of working; even when client was ready to give up as per Western ways.

Finally co development partnership happened in next few months with one company in Oncology.

Second company took more time and couple of visits before signing co-development deal for ophthalmic therapy.

Client signed co-development deals with 2 companies in Oct and Dec 2013 respectively

Right companies, right advice, structure, perseverance and commitment were the key success factor. in making it happen.

Aagami proved highly influential in negotiations for finalization of the deals due to deep experience in business culture nuances of India.

It brought repeat and referral business to Aagami.